The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
New Insights About Albumin and Liver Disease
Open accessAbstract
Decompensated liver cirrhosis has a dismal prognosis, with an overall survival of 2-4 years, which is worse than for many oncological diseases. Albumin is an important tool in the management of patients with cirrhosis, since it decreases for less than half the risk for post-paracentesis cardiocirculatory dysfunction and mortality associated with spontaneous bacterial infection, as well as, it triplicates the response to terlipressin in patients with hepatorenal syndrome. Recently, research on albumin has been a hot topic, with important new insights such as the characterization of the pleiotropic effects of albumin (which surpass its oncotic properties) and the concept of effective albumin concentration. In fact, patients with liver cirrhosis present posttranslational modifications on albumin that compromises its function. Those modified albumin forms were proved to have prognostic value and its knowledge may change the paradigm of albumin treatment. In this review, we critically summarize the latest evidence on the potential benefits of albumin in patients with end-stage liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levitt, D., & Levitt, M. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s102819 · Cited by 763
Serum Albumin Level and Physical Disability as Predictors of Mortality in Older Persons
Corti, M.-C. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520130074036 · Cited by 672
The glycation of albumin: Structural and functional impacts
Rondeau, P., & Bourdon, E. (2011) · Biochimie · doi:10.1016/j.biochi.2010.12.003 · Cited by 433
Nagumo, K., Tanaka, M., Chuang, V. T. G., Setoyama, H., Watanabe, H., Yamada, N., Kubota, K., Tanaka, M., Matsushita, K., Yoshida, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085216 · Cited by 201
Cited by
The Uniqueness of Albumin as a Carrier in Nanodrug Delivery
Spada, A., Emami, J., Tuszynski, J. A., & Lavasanifar, A. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00046 · Cited by 591
Wang, H., Yao, W., Wang, Y., Dong, H., Dong, T., Zhou, W., Cui, L., Zhao, L., Zhang, Y., Shi, L., et al. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03494-2 · Cited by 28
Survival of endogenous hepatic stem/progenitor cells in liver tissues during liver cirrhosis
Chen, Q., You, X., Yang, W., Jiang, S., Lai, J., Zhang, H., & Bai, L. (2020) · Life Sciences · doi:10.1016/j.lfs.2019.117121 · Cited by 23
Hu, D., Lai, J., Chen, Q., & Bai, L. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03817-x · Cited by 6
Metadata
- Authors
- Carvalho, J. R., & Machado, M. V.
- Venue
- Annals of Hepatology
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 17
- Issue
- 4
- Pages
- 547-560
- ISSN
- 1665-2681 (ISSN-L)
- OpenAlex
- W2808338426
- Cited by
- 229
- References
- 4
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New Insights About Albumin and Liver Disease. https://app.cochat.ai/papers/10.5604/01.3001.0012.0916
- The paper
- Carvalho, J. R., & Machado, M. V. (2018). New Insights About Albumin and Liver Disease. Annals of Hepatology. https://doi.org/10.5604/01.3001.0012.0916
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.